# TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.

> **NCT03357874** · PHASE3 · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 259 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT03357874
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-28
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-07-18
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2025-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03357874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03357874, "TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03357874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*